- Home
- QLGN vs RHE Comparison
QLGN vs RHE Comparison
Compare QLGN & RHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QLGN
- RHE
- Stock Information
- Founded
- QLGN 1996
- RHE 1988
- Country
- QLGN United States
- RHE United States
- Employees
- QLGN N/A
- RHE N/A
- Industry
- QLGN Biotechnology: Pharmaceutical Preparations
- RHE Real Estate
- Sector
- QLGN Health Care
- RHE Real Estate
- Exchange
- QLGN Nasdaq
- RHE Nasdaq
- Market Cap
- QLGN 3.4M
- RHE 2.9M
- IPO Year
- QLGN N/A
- RHE 2006
- Fundamental
- Price
- QLGN $4.18
- RHE $1.55
- Analyst Decision
- QLGN
- RHE
- Analyst Count
- QLGN 0
- RHE 0
- Target Price
- QLGN N/A
- RHE N/A
- AVG Volume (30 Days)
- QLGN 54.9K
- RHE 17.3K
- Earning Date
- QLGN 11-14-2024
- RHE 11-19-2024
- Dividend Yield
- QLGN N/A
- RHE N/A
- EPS Growth
- QLGN N/A
- RHE N/A
- EPS
- QLGN N/A
- RHE N/A
- Revenue
- QLGN N/A
- RHE $15,753,000.00
- Revenue This Year
- QLGN N/A
- RHE N/A
- Revenue Next Year
- QLGN N/A
- RHE N/A
- P/E Ratio
- QLGN N/A
- RHE N/A
- Revenue Growth
- QLGN N/A
- RHE N/A
- 52 Week Low
- QLGN $3.34
- RHE $1.13
- 52 Week High
- QLGN $30.50
- RHE $3.08
- Technical
- Relative Strength Index (RSI)
- QLGN 43.01
- RHE 44.73
- Support Level
- QLGN $3.53
- RHE $1.38
- Resistance Level
- QLGN $4.39
- RHE $1.57
- Average True Range (ATR)
- QLGN 0.33
- RHE 0.07
- MACD
- QLGN 0.06
- RHE -0.01
- Stochastic Oscillator
- QLGN 50.98
- RHE 43.93
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.
About RHE Regional Health Properties Inc.
Regional Health Properties Inc is a self-managed healthcare real estate investment company that invests in real estate purposed for senior living and long-term healthcare through facility lease and sub-lease transactions. It has two reportable segments real estate segment and the healthcare services segment. It derives the majority of its revenue from the healthcare services segment. Its portfolio of properties is diversified across various states, with concentrations in Georgia and Ohio.